Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Comparative effectiveness of anti-fibrosis treatment in patients after HCV infection and in patients with non-alcoholic fatty liver disease (NAFLD)
Gavryliuk, Nadiia, Hospodarskyy, Ihor, Prokopchuk, Oksana, Krekhovska-Lepiavko, Olha, Lokay, Borys, Havrylyuk, Mykhailo
Published in Journal of education, health and sport (26.02.2021)
Published in Journal of education, health and sport (26.02.2021)
Get full text
Journal Article
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
Feagan, Brian G, Danese, Silvio, Loftus, Edward V, Vermeire, Séverine, Schreiber, Stefan, Ritter, Timothy, Fogel, Ronald, Mehta, Rajiv, Nijhawan, Sandeep, Kempiński, Radosław, Filip, Rafał, Hospodarskyy, Ihor, Seidler, Ursula, Seibold, Frank, Beales, Ian L P, Kim, Hyo Jong, McNally, John, Yun, Chohee, Zhao, Sally, Liu, Xiaopeng, Hsueh, Chia-Hsiang, Tasset, Chantal, Besuyen, Robin, Watanabe, Mamoru, Sandborn, William J, Rogler, Gerhard, Hibi, Toshifumi, Peyrin-Biroulet, Laurent
Published in The Lancet (British edition) (19.06.2021)
Published in The Lancet (British edition) (19.06.2021)
Get full text
Journal Article
Fr531 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY
Peyrin-Biroulet, Laurent, Loftus, Edward V., Danese, Silvio, Vermeire, Séverine, Sandborn, William J., Fogel, Ronald P., Nijhawan, Sandeep, Kempinski, Radoslaw, Filip, Rafal, Hospodarskyy, Ihor, McNally, John, Yun, Chohee, Zhao, Sally, Liu, Xiaopeng, Tasset, Chantal T., Besuyen, Robin, Watanabe, Mamoru, Schreiber, Stefan, Rogler, Gerhard, Hibi, Toshifumi, Feagan, Brian G.
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2021)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2021)
Get full text
Journal Article
Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial
Suh, Chang-Hee, Yoo, Dae Hyun, Berrocal Kasay, Alfredo, Chalouhi El-Khouri, Elia, Cons Molina, Francisco Fidenci, Shesternya, Pavel, Miranda, Pedro, Medina-Rodriguez, Francisco G., Wiland, Piotr, Jeka, Slawomir, Chavez-Corrales, Jose, Linde, Thomas, Hrycaj, Pawel, Abello-Banfi, Mauricio, Hospodarskyy, Ihor, Jaworski, Janusz, Piotrowski, Mariusz, Brzosko, Marek, Krogulec, Marek, Shevchuk, Sergii, Calvo, Armando, Andersone, Daina, Park, Won, Shim, Seung Cheol, Lee, Sang Joon, Lee, Sung Young
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.02.2019)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.02.2019)
Get full text
Journal Article